Surprisingly, we show that inactivation of mTORC1 both pharmacologically (Rapamycin) and by reducing expression (Raptor shRNA) induces macropinocytosis and enhances cancer growth (Figure 4; Supplemental Figure 5). Here, RPTOR is linked to cancer.